Rheumatoid arthritis risk associates with DNA repair gene XRCC1 Arg399Gln polymorphism in Turkish patients.
Rheumatoid arthritis (RA) is an autoinflammatory disease with a genetic background. The synoviocytes in RA shows cellular transformation with tumor-like features, and RA patients have genomic instability and relaxation of DNA repair mechanisms. The polymorphisms in BER repair pathway genes, XRCC1 and OGG1, may change the response to inflammation via altered DNA repair capacity. In this study, we aimed to investigate the relationship between the risk of RA and XRCC1 Arg194Trp, Arg399Gln, and OGG1 Ser326Cys polymorphisms in a group of Turkish RA patients. XRCC1 Arg194Trp, Arg399Gln, and OGG1 Ser326Cys polymorphisms were investigated by PCR-RFLP method in 100 RA patients and 158 healthy control subjects. The results were statistically analyzed by calculating the odds ratios (OR) and their 95% confidence intervals (95% CI) using the χ(2)-tests. RA patients in this study had significantly higher frequencies of XRCC1 Arg399Gln polymorphism in both homozygote (GG) (35%, OR: 7.78 [95% CI: 3.65-16.59], P < 0.001) and heterozygote (AG) forms (41%, OR: 2.17 [95% CI: 1.19-3.96], P < 0.01) and also increased frequency of 399Gln (G) allele (55%, OR:2.99 [95% CI: 1.67-5.37], P < 0.001). We conclude that XRCC1 Arg194Trp, and OGG1 Ser326Cys polymorphisms are not associated with RA; however, Arg399Gln polymorphism is a significant risk factor of RA, and carriers of 399Gln (G) allele have greater risk of RA.
Department of Medical Genetics, Cerrahpasa Medical School, Istanbul University, Selamicesme Goktepe sok. No:3/26 Kadikoy, Istanbul, Turkey. yosunkayafenerci@hotmail.com
Elif
E
Yosunkaya
Funda
F
Karakurt
Esra
E
Cetin
Levent
L
Ozgonenel
Ilhan
I
Onaran
Bahadir
B
Batar
Mehmet
M
Guven
Gonul Kanigur
GK
Sultuybek
D001172:Arthritis, Rheumatoid / Q000208:ethnology / Q000235:genetics*; D016022:Case-Control Studies; D016009:Chi-Square Distribution; D045647:DNA Glycosylases / Q000235:genetics; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000235:genetics*; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D016017:Odds Ratio; D010641:Phenotype; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D018570:Risk Assessment; D012307:Risk Factors; D014421:Turkey / Q000453:epidemiology; D000076105:X-ray Repair Cross Complementing Protein 1
D004268:DNA-Binding Proteins; D000076105:X-ray Repair Cross Complementing Protein 1; C000619371:XRCC1 protein, human; D045647:DNA Glycosylases; C479058:oxoguanine glycosylase 1, human
Arthritis Res Ther. 2009;11(5):248
19849816
Arthritis Res Ther. 2004;6(6):265-78
15535839
Rheumatol Int. 2006 Jun;26(8):749-51
16284769
Biomed Pharmacother. 2006 Dec;60(10):656-62
17055211
Nucleic Acids Res. 2010 May;38(9):2878-90
20071746
FASEB J. 2005 Feb;19(2):290-2
15677345
Am J Epidemiol. 2005 Nov 15;162(10):925-42
16221808
Int J Toxicol. 2006 Sep-Oct;25(5):419-22
16940014
Lupus. 2009 Dec;18(14):1246-51
19880550
J Immunol. 2003 Feb 15;170(4):2214-20
12574395
Oncogene. 1998 Jun 25;16(25):3219-25
9681819
J Clin Invest. 2008 Jul;118(7):2516-25
18521188
Protein J. 2007 Dec;26(8):541-6
17899335
J Biol Chem. 2003 Nov 7;278(45):44068-74
12933815
Curr Opin Rheumatol. 2010 Mar;22(2):109-18
20075733